-+ 0.00%
-+ 0.00%
-+ 0.00%

BIONTECH SE: PUMITAMIG PLUS CHEMOTHERAPY DEMONSTRATED MANAGEABLE SAFETY PROFILE IN BOTH COHORTS WITH ALL FOUR CHEMOTHERAPY REGIMENS

Reuters·12/09/2025 12:00:03

Please log in to view news